24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Chengdu Kanghong Pharma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:28
Full list of Israeli startup M&As in 2025
17:24
Fintech unicorn Tipalti acquires Statement for $35-45M to expand real-time cash flow management
15:02
Full list of Israeli high-tech funding rounds in 2025
15:00
Coralogix raises $115 million Series E at over $1 billion valuation
More stories
Buzz
Most popular
Daily
Weekly
1
Coralogix raises $115 million Series E at over $1 billion valuation
2
“We made another investment the morning after the war with Iran began”
3
Fintech unicorn Tipalti acquires Statement for $35-45M to expand real-time cash flow management
4
Intel to begin foundry layoffs in July, but uncertainty hangs over Israel amid wartime reality
5
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
More news
Chengdu Kanghong Pharma
2 stories about Chengdu Kanghong Pharma
Chengdu Kanghong Pharma Solidifies Ownership of Israeli Medical Device Company
27.09.18
|
Lilach Baumer
The company paid $7 million in 2017 for 19% of IOPtima, a developer of minimally invasive devices for eye surgery
Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima
21.11.17
|
Lilach Baumer
The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange
